CLINICAL_TRIALS
trial_result
· 2014-06-06
Clinical Trial Update: An Efficacy Study of Paliperidone for the Prevention of Relapse in Participants With Schizophrenia [Phase 3]
Summary
This document reports results from a Phase 3 trial evaluating paliperidone for preventing relapse in people with schizophrenia. The results were posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Research & Development, LLC | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2014-06-06